DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?

Major depressive disorder (MDD) is a debilitating psychiatric disorder, the third leading global cause of disability. Regarding aetiopathogenetic mechanisms involved in the onset of depressive disorders, the interaction between genetic vulnerability traits and environmental factors is believed to pl...

Full description

Saved in:

Bibliographic Details
Published in:	Current neuropharmacology Vol. 20; no. 12; p. 2267
Main Authors:	Paoli, Caterina, Misztak, Paulina, Mazzini, Giulia, Musazzi, Laura
Format:	Journal Article
Language:	English
Published:	United Arab Emirates 15.11.2022
Subjects:	Animals Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Biomarkers Depression - genetics Depressive Disorder, Major - drug therapy Depressive Disorder, Major - genetics DNA Epigenesis, Genetic Phenotype DNA methylation Depression animal model biomarker epigenetics antidepressant
ISSN:	1875-6190, 1875-6190
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!